Leflunomide Tablet
Product Images NDC 60505-2502

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 60505-2502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg-30btl.jpg (20mg 30btl)

These are tablets of Leflunomide with a strength of 20 mg. They should be stored between the temperature range of 15°C to 20°C and protected from light. The tablets should be dispensed in a container that is airtight and light-resistant. The usual dosage is mentioned in the package insert. The manufacturer of these tablets is Apotex Corp. The rest of the text is not legible.*

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

The text is presenting a graph showing the percentage of responders over time for Trial 1 ACR. The graph shows data for a period of 6 months. The x-axis shows different time intervals and the y-axis shows the percentage of responders. The graph includes labels for different treatments or interventions: pL, 0+, NTX, and LEF. The meaning of these labels is not clear from the text, but the graph suggests they are related to the level of response to some treatment. The footnote indicates that the graph is based on the "Last Observation Carried Forward" method.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Lbl10mg30s

This is a medication called Leflunomide, each tablet contains 10mg of the active ingredient. The medicine should be stored in a container that protects it from light and kept at an average temperature of 25°C (77°F), with excursions permitted from 15° to 30°C (59°F to 86°F). The usual dosage information can be found in the package insert. This particular package contains 30 tablets and it was manufactured by Apotex Inc. in Toronto, Canada, exclusively for TAC Corp in Florida. The NDC number is 60505-2502.*

FDA Label Image

Structure1.jpg (Structure1)

FDA Label Image

Structure2.jpg (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.